CANOPY GROWTH ANNOUNCES COMPLETION OF STUDY ON THE LONG-TERM EFFECTS OF CBD

Study represents the first research completed on the long-term toxicity and lifespan effects of cannabidiol in the preclinical model C. elegans   SMITHS FALLS, ON— Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED NASDAQ:CGC) and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term effects of cannabidiol (CBD),…

Continue Reading

Canopy Growth Continues Its 2.0 Product Innovation Rollout With New Beverage, Chocolate and Vape Products Arriving In Market

SMITH FALLS, ON— Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) officially unveiled its Cannabis 2.0 portfolio in late 2019 and is pleased to provide the following updates on the Company’s 2.0 innovation products that have launched into the Canadian recreational market in early 2020, and additional upcoming product releases. The first wave…

Continue Reading

Canopy Growth Receives Health Canada Licence for State-of-the-Art Beverage Facility

Canopy Growth Now Has All “Cannabis 2.0” Related Licences Required for Vapes, Beverages, and Chocolates Now in Hand November 25, 2019 SMITHS FALLS, ON— Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) is pleased to announce today that on November 22, 2019, it received its operating and secure storage licence from Health Canada…

Continue Reading

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals

SMITHS FALLS, ON – Spectrum Therapeutics, the medical division of Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED) (NYSE: CGC) is pleased to announce that it has partnered with Tree of Knowledge International Corp. (“Tree of Knowledge”) (CSE:TOKI) (OTC:TOKIF) to provide education and support for patients and their healthcare professionals working within the Tree of Knowledge…

Continue Reading

European Update: Canopy Growth Secures Exclusive Opportunities in the UK and Luxembourg

Receives first UK licence for a storage and distribution facility dedicated to medicinal cannabis, under the MHRA ‘specials’ program for unlicensed medicines Wins exclusive contract to supply medical cannabis in Luxembourg, connecting country to Canopy Growth’s European network SMITHS FALLS, ON – OXFORD – FRANKFURT —Canopy Growth Corporation (TSX:WEED, NYSE:CGC) (“Canopy Growth” or the “Company”),…

Continue Reading

Spectrum Therapeutics Announces Donation to Support Research and Education Initiatives led by the Canadian Sleep and Circadian Network

SMITHS FALLS, ON and MONTREAL, QC – Spectrum Therapeutics (“Spectrum”), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce a donation to the Fondation de l’Hôpital du Sacré-Coeur de Montreal (Montreal Sacre Coeur Hospital Foundation) to support the Canadian Sleep and Circadian Network’s (“CSCN”) associated national campaign: Sleep On It which aims…

Continue Reading